De Laet C, Carlier C, Robert M, Thiebaut I, Prové G, Sergooris R, Goyens P
Unité de Nutrition et Métabolisme, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Bruxelles.
Rev Med Brux. 2006;27 Spec No:Sp74-7.
The concept "inborn error of metabolism" (IEM) arose from the observations of Sir A. Garrod at the beginning of the XXth century. The exponential development, during the last decades, of our knowledge in cellular biology and molecular genetics, and the availability of increasingly more precise diagnostic tools, allow the identification of a still growing number of inborn errors of metabolism. Their physiopathology is better understood. Treatments have considerably improved: more specific diets, new medical treatments, enzyme replacement therapy, organ transplantation, hepatocyte or stem cell transplantation... New techniques are under development, including various strategies of gene therapy. Improved therapeutic efficacy combined with earlier diagnosis have dramatically changed the prognosis of many disorders. As a consequence, new challenging questions have to be answered. Today, patients with an IEM, because of the extreme complexity of their management, need to be looked after by a multidisciplinary team of physicians (pediatricians and internists), dieticians, social workers, psychologists... It is essential, in this complex and rapidly expanding field, that experiences should be shared at national and international level, in order to provide the most adequate care for patients.
“先天性代谢缺陷”(IEM)这一概念源于20世纪初A. 加罗德爵士的观察。在过去几十年里,我们在细胞生物学和分子遗传学方面的知识呈指数级增长,且诊断工具越来越精确,这使得能够识别出数量仍在不断增加的先天性代谢缺陷。对其病理生理学有了更好的理解。治疗方法有了显著改进:更特殊的饮食、新的药物治疗、酶替代疗法、器官移植、肝细胞或干细胞移植……新技术正在研发中,包括各种基因治疗策略。治疗效果的提高与早期诊断相结合,极大地改变了许多疾病的预后。因此,必须回答一些新的具有挑战性的问题。如今,由于管理先天性代谢缺陷患者极其复杂,需要由多学科医生团队(儿科医生和内科医生)、营养师、社会工作者、心理学家等来照料。在这个复杂且迅速发展的领域,在国家和国际层面分享经验至关重要,以便为患者提供最充分的护理。